XCUR Competitors & Alternatives
Compare Exicure Inc with similar stocks in the same industry
Biotechnology
XCUR
Main Stock$1.91
Tradestie Score
50
Market Cap
$25.90M
Revenue Growth
9.3%
Analyst Upside
+4.7%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANRO
Alto Neuroscience Inc.
|
$24.78
|
$110.20M | - | 58 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.69
|
$97.42M | - | 55 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$30.43
|
$76.55M | - | 58 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.28
|
$71.69M | - | 52 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.34
|
$67.94M | - | 56 | Compare |
|
PHIO
Phio Pharmaceuticals Corp. Common Stock
|
$1.00
|
$13.86M | - | 46 | Compare |
|
ENSC
Ensysce Biosciences, Inc. Common Stock
|
$0.28
|
$7.21M | - | 54 | Compare |
|
QNRX
Quoin Pharmaceuticals, Ltd. American Depositary Shares
|
$4.58
|
$4.25M | - | 52 | Compare |
|
DRMA
Dermata Therapeutics, Inc. Common Stock
|
$1.34
|
$3.50M | - | 49 | Compare |
|
ATXI
ATXI
|
- | - | - | - | Compare |
More XCUR Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2834)
237 stocks in this industry